BioMime | Drug Eluting Stents for heart attack after Chest Pain | Meril Vascular Intervention

BioMime

BioMime is a Sirolimus drug eluting coronary stent system with an ultra-thin (65 µm) strut thickness for bypass surgery and chest pain treatment.

This next generation (SES) has a Novel Hybrid Design with closed cells (on both ends of the stent) & open cells (in the middle)- this allows for Morphology Mediated Expansion for adequate conformability and lesser edge dissections.

BioPoly-Biodegradable Polymer: 2µm low thickness, stable and elastic polymer.

Stent design with non-linear S links & Y connectors allowing high flexibility and adequate side branch access. Strut width variability ensures optimal radial strength.

Low balloon over hang of less than 0.5mm to minimize healthy vessel injury.
Available in more than 94 Countries worldwide with more than 500,000 stents deployed.

meriT Trials: Consistent data in more than 1,700 patients upto 5 years follow-up.

Non Inferiority to XIENCE DES proven in meriT-V: published in Eurointervention (Sep'18)

Visit our website to learn more about the product.